Headline News

 

Dr. Reddy’s Laboratories announces the launch of Hydroxychloroquine Sulfate Tablets

Posted on July 17, 2018

Phase III CAPSTONE-2 study showed that baloxavir marboxil reduced symptoms in people at high risk of complications

Posted on July 17, 2018

Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets by Teva Pharmaceuticals USA

Posted on July 17, 2018

Lupin’s Goa facility gets UK MHRA approval

Posted on July 17, 2018

Glenmark Pharmaceuticals receives ANDA approval for Colesevelam Hydrochloride for Oral Suspension

Posted on July 17, 2018

Aurobindo Signs a Definitive Agreement to Acquire Apotex’ Businesses in Europe

Posted on July 17, 2018

NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA

Posted on July 10, 2018

Dr. Reddy’s and UCB India enter into an agreement to co-promote and distribute Briviact®

Posted on July 10, 2018

Lynparza for use beyond ovarian cancer Second approval in Japan for AstraZeneca and MSD’s Lynparza

Posted on July 10, 2018

Suven Life Sciences secures Product Patents in India, Singapore, South Korea and Israel

Posted on July 10, 2018

Zydus Cadila – tentative approval from the USFDA for Deferasirox Tablets for Oral Suspension

Posted on July 10, 2018

Glenmark Pharmaceuticals Announces Exclusive Licensing Agreement with Seqirus for its Investigational Seasonal Allergic Rhinitis Nasal Spray – Ryaltris

Posted on July 10, 2018

Akshay Kumar as Revital H Brand Ambassador at Sun Pharma

Posted on July 10, 2018

WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center

Posted on July 03, 2018

Catalent Signs Agreement To Acquire Juniper Pharmaceuticals, Inc.

Posted on July 03, 2018